O. Legrand

440 citations
8 papers · 236 · h-index 6

Impact in

  • Hematology top 10%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
    • Polyomavirus and related diseases
    • Drug Transport and Resistance Mechanisms

Papers in

    • Polyomavirus and related diseases 1
    • Neutropenia and Cancer Infections 1
    • Acute Myeloid Leukemia Research 3
    • Chronic Myeloid Leukemia Treatments 1

O. Legrand

8 papers receiving 225 citations

Peers

O. Legrand
Comparison fields: 5 of 45
  • Hematology 133
  • Oncology 86
  • Transplantation 7
  • Public Health, Environmental and Occupational Health 52
  • Genetics 19
Replace Katarzyna Jamieson with:
Katarzyna Jamieson United States
Zhengzheng Fu China
K. De Leeuw Netherlands
Wenyu Yang China
D-C Zhou France
Atelda Romano Italy
Goda Choi Netherlands
Tomoko Yokosuka Japan
Falk Heidenreich Germany
Da-Cheng Zhou France
O. Legrand relative to Katarzyna Jamieson United States Katarzyna Jamieson's profile →
Citations per field
00.5×1.5×1.8×
Katarzyna Jamieson · 1×
Citations per year

Countries citing papers authored by O. Legrand

Since Specialization
Citations

This map shows the geographic impact of O. Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Legrand more than expected).

Fields of papers citing papers by O. Legrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Legrand. The network helps show where O. Legrand may publish in the future.

Co-authors

The 25 scholars most cited alongside O. Legrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with O. Legrand Line = papers co-authored together O. Legrand links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 201560
2 201057
3 200647
4 199832
5 200028
6 19997
7 20253
8
CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE
19932

About O. Legrand

O. Legrand is a scholar working on Oncology, Hematology, Molecular Biology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 8 papers that have together received 236 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Mycobacterium research and diagnosis (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), Polyomavirus and related diseases (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (133 citations), Oncology (86 citations), Transplantation (7 citations), Public Health, Environmental and Occupational Health (52 citations) and Genetics (19 citations). O. Legrand has collaborated with scholars based in France, Italy and Belgium. Frequent co-authors include R Zittoun, Ghislaine Simonin, J. P. Marie, Anne Vekhoff, Philippe Rousselot, Sylvie Chevret, Christophe Bardin, Bernard Rio, F. Chast and Driss Chaoui. Their work appears in journals such as British Journal of Haematology, Haematologica, British Journal of Cancer, Blood Advances and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact